| |
|
Who's Online |
|
We have 30 guests online |
|
|
|
|
|

|
Upcoming Events |
Burma Uprising Anniversary- Fri, Aug 8th, 2008, @12:00am- 12:00pm
|
Better Biking Brainstorming Session- Thu, Aug 14th, 2008, @7:00pm- 9:00pm
|
Missing Women Conference Opens- Thu, Aug 14th, 2008, @3:00pm- 9:00pm
|
Weyburn Zero Waste Convention Opens- Fri, Aug 15th, 2008, @9:00am- 5:00pm
|
100 Mile Potluck- Tue, Aug 26th, 2008, @5:30am- 8:00pm
|
Briarpatch Birthday- Wed, Sep 10th, 2008, @7:30pm- 8:30pm
|
Aboriginal Music Festival - Saskatoon- Fri, Sep 19th, 2008, @6:00pm- 11:00pm
|
Naomi Klein Lecture - Regina- Tue, Sep 23rd, 2008, @7:30am- 8:30pm
|
|
|
|
|
|
| |
Pathway :: Home
|
Blaming the Brain ... Another Look at "Mental Illness" |
|
|
|
|
Contributed by Werner Scott
|
|
Wednesday, 02 July 2008 |
This is item that i published on my own blog. I felt that it was important enough to be submitted to our Saskatchewan indymedia site. The article consists of some introductory paragraphs in front of quotations from several sources. The subject deals with recent coverage by the Globe and Mail newspaper on the issue of "mental illness".
In light of recent aggressive efforts by Canada's "national newspaper" the Globe and Mail
to promote major psychological difficulties as "mental illness" here is
a replay of a short essay from one of the original major critics of
psychiatry, the man who 'started it all'. Thomas Szasz MD is widely
known as author of The Myth of Mental Illness (1960) and The Manufacture of Madness: A Comparative Study of the Inquisition and the Mental Health Movement (1970).
Not very long ago I tried to add a portion of an earlier blog entry to a comment trail on a portion of the Globe's website dedicated to this issue. My item quoted an article published in the Canadian Journal of Psychiatry
in 2007. That item denied any biophysical foundation to depression such
as reduced hippocampal volume and suggested that such reduction might
be the result of drug treatments in the same fashion as
"antipsychotics have been shown to do in patients with psychosis".
Also
the author pointed out that "if I experience an adverse event, I will
feel sad, and if this emotion is strong enough, there are likely to be
associated biochemical changes - but it is the event that has made me
sad, not the chemical fluctuations". Despite these references my
comment was not included although scores of anecdotal "first person"
contributions passed muster.
MENTAL ILLNESS AS A NAME FOR PROBLEMS IN LIVING
The
term "mental illness" is widely used to describe something which is
very different than a disease of the brain.Many people today take it·
for granted that living is an arduous process. Its
hardship for modern man, moreover, derives not so much from a struggle
for biological survival as from the stresses and strains inherent in
the social intercourse of complex human personalities. In
this context, the notion of mental illness is used to identify or
describe some feature of an individual's so-called personality. Mental
illness -- as a deformity of the personality, so to speak -- is then
regarded as the cause of the human disharmony. It is implicit in this
view that social intercourse between people is regarded as something
inherently harmonious, its disturbance being due solely to the presence
of "mental illness" in many people. This is obviously fallacious
reasoning, for it makes the abstraction "mental illness" into a cause,
even though this abstraction was created in the first place to serve
only as a shorthand expression for certain types of human behavior. It
now becomes necessary to ask: "What hinds of behavior are regarded as
indicative of mental illness, and by whom?" The concept of illness, whether bodily or mental, implies deviation from some clearly defined norm. In
the case of physical illness, the norm is the structural and functional
integrity of the human body. Thus, although the desirability of
physical health, as such, is an ethical value, what health is can be stated in anatomical and physiological terms. What is the norm deviation from which is regarded as mental illness? This question cannot be easily answered. But whatever this norm might be, we can be certain of only one thing: namely, that it is a norm that must be stated in terms of psycho-social, ethical, and legal concepts. For
example, notions such as "excessive repression" or "acting out an
unconscious impulse" illustrate the use of psychological concepts for
judging (so-called) mental health and illness. The
idea that chronic hostility, vengefulness, or divorce are indicative of
mental illness would be illustrations of the use of ethical norms (that
is, the desirability of love, kindness, and a stable marriage
relationship). Finally, the widespread
psychiatric opinion that only a mentally ill person would commit
homicide illustrates the use of a legal concept as a norm of mental
health. The norm from which deviation is measured whenever one speaks
of a mental illness is a psycho-social and ethical one. Yet, the remedy is sought in terms of medical measures which -- it is hoped and assumed -- are free from wide differences of ethical value. The definition of the disorder and the terms in which its remedy are sought are therefore at serious odds with one another. The
practical significance of this covert conflict between the alleged
nature of the defect and the remedy can hardly be exaggerated. Having
identified the norms used to measure deviations in cases of mental
illness, we will now turn to the question: "Who defines the norms and
hence the deviation?" Two basic answers may be offered: (a) It may be the person himself (that is, the patient) who decides that he deviates from a norm. For example, an artist may believe that he suffers from a work inhibition; and he may implement this conclusion by seeking help for himself from a psychotherapist. (b)
It may be someone other than the patient who decides that the latter is
deviant (for example, relatives, physicians, legal authorities, society
generally, etc.). In such a case a psychiatrist may be hired by others to do something to the patient in order to correct the deviation. These
considerations underscore the importance of asking the question "Whose
agent is the psychiatrist?" and of giving a candid answer to it (Szasz,
1956, 1958). The psychiatrist (psychologist or
nonmedical psychotherapist), it now develops, may be the agent of the
patient, of the relatives, of the school, of the military services, of
a business organization, of a court of law, and so forth. In speaking
of the psychiatrist as the agent of these persons or organizations, it
is not implied that his values concerning norms, or his ideas and aims
concerning the proper nature of remedial action, need to coincide
exactly with those of his employer. For example,
a patient in individual psychotherapy may believe that his salvation
lies in a new marriage; his psychotherapist need not share this
hypothesis. As the patient's agent, however, he must abstain from
bringing social or legal force to bear on the patient which would
prevent him from putting his beliefs into action. If his contract is
with the patient, the psychiatrist (psychotherapist) may disagree with
him or stop his treatment; but he cannot engage others to obstruct the
patient's aspirations. Similarly, if a psychiatrist is engaged by a
court to determine the sanity of a criminal, he need not fully share
the legal authorities' values and intentions in regard to the criminal
and the means available for dealing with him. But the psychiatrist is
expressly barred from stating, for example, that it is not the criminal
who is "insane" but the men who wrote the law on the basis of which the
very actions that are being judged are regarded as "criminal." Such
an opinion could be voiced, of course, but not in a courtroom, and not
by a psychiatrist who makes it his practice to assist the court in
performing its daily work.  To recapitulate:
In actual contemporary social usage, the finding of a mental illness is
made by establishing a deviance in behavior from certain psychosocial,
ethical, or legal norms. The judgment may be made, as in medicine, by the patient, the physician (psychiatrist), or others. Remedial
action, finally, tends to be sought in a therapeutic -- or covertly
medical -- framework, thus creating a situation in which psychosocial, ethical, and/or legal deviations are claimed to be correctible by (so-called) medical action. Since
medical action is designed to correct only medical deviations, it seems
logically absurd to expect that it will help solve problems whose very
existence had been defined and established on nonmedical grounds. I
think that these considerations may be fruitfully applied to the
present use of tranquilizers and, more generally, to what might be
expected of drugs of whatever type in regard to the amelioration or
solution of problems in human living.
One
of the myths perpetuated by the Globe and Mail in their oped pages is
the idea that the emptying of the mental hospitals was due to the
"fortunate" introduction of major tranquilizers like chlorpromazine
(marketed as Thorazine). Several commentators like Peter Breggin author
of Toxic Psychiatry have disputed this claim saying that
de-institutionalization was mainly an issue of economics. From the British Journal of Psychiatry Leon Eisenberg MD, a less severe critic of psychiatry, wrote in 2000
"They (neurolyptics)
were credited with emptying the mental hospitals, although the onset of
de-institutionalisation had preceded the introduction of the drugs. In
catchment areas where ‘open hospital’ and ‘community psychiatry’
policies had been implemented, drugs had relatively little additional
effect on length of hospital stay (Shepherd et al, 1961), but they were
decisive in hospitals where patients continued to be warehoused
(Odegaard, 1964). De-institutionalisation in the USA was driven more
powerfully by economic forces (cost-shifting from state to federal
budgets) than by theory or data. The decline of the mental hospital
census was celebrated without finding out where the former patients
were. Elderly patients were ‘trans-institutionalised’ to nursing homes;
many long-stay patients were discharged to home addresses that no
longer existed, and became street people. Calls to evaluate the
community mental health movement (Eisenberg, 1968) were as unavailing
as earlier critiques of psychoanalysis."
AND ... from the Manchester Guardian (Feb 27/08):
The creation of the Prozac myth
In
the 20 years since its launch, 40 million people worldwide have taken
the so-called wonder drug - but research revealed this week shows that
Prozac, and similar antidepressants, are no more effective than a sugar
pill. So how was the myth created? Psychoanalyst Darian Leader traces
the irrepressible rise of the multibillion dollar depression industry,
while others explore the clinical and cultural impact of Prozac, its perceived personal benefits- and sometimes terrible costs
Has
the depression bubble finally burst? Yesterday's headlines about the
inefficacy of Prozac and other bestselling antidepressants must have
been an unpleasant shock, not only to the drug manufacturers, but also
to the millions of people in the UK taking these drugs. The new
research, published in the Public Library of Science Journal,
found that a placebo was just as effective as the drugs - excepting in
some cases of severe depression, where it was not the drugs that did
well, but the placebos that did worse.
What will the impact of
this new research be? Is it a case of recognising that the Prozac
emperor never had any clothes? Or, on the contrary, of acknowledging
the power of placebo and finding new ways of working with it?
For
many researchers, the PLoS findings actually reveal nothing new.
Several earlier studies comparing placebo with antidepressant drugs had
found that there was not much difference, yet these results had little
media uptake. The new paper owes its coverage partly to the fact that
it includes data from clinical trials that the manufacturers chose not
to broadcast. As criticism of the industry's withholding of such
results mounted, drug companies were forced to make unflattering
results public.
It is only very recently that this has become a
legal obligation. In the heyday of antidepressant PR, only about 10% of
results about how the drugs affected quality of life were published.
More than two-thirds of studies today are industry funded, and such
research is four times as likely to find in favour of the drugs than
independent inquiry. It is hardly surprising, then, that research has
tended to give a positive spin to antidepressants.
The new
negative results might seem to promise a change of direction. But they
may just be the other side of the industry coin. What remains
unchallenged is the diagnosis of depression itself. GPs diagnose it
every minute of the day, celebrities reveal they suffer from it and
soap opera characters wrestle with it. Yet 40 years ago depression was
hardly anywhere. A tiny percentage of the population were deemed to
suffer from it. So what happened?
These developments actually
followed a surprising course. The story of depression cannot be
dissociated from the story of its supposed remedies. And these, like
nearly all psychotropic drugs, were not the result of targeted
research, but of chance association. The first drugs had in fact been
used as antihistamines, yet they seemed to have effects on mood, energy
and anxiety.
Although epidemiological studies had found high
levels of nervous conditions in the community before these drugs were
marketed, this had not been diagnosed as depression. With the marketing
of the drugs, this nervous substrata was now labelled as a depression
which had gone unrecognised and untreated. Yet this knowledge was not
seized on and marketed until the drugs market made this happen in the
late 70s.
Where depression had been rated at 50 per million in
the early 60s, by the 90s this had jumped to 100,000. These remarkable
changes coincided with the crisis in the market for minor tranquilisers
such as Librium and Valium,
prescribed for anxiety. As these widely used drugs were found to be
highly addictive, it looked as if a substantial market was about to
collapse. Hundreds of thousands of people took these drugs and the
economic gains were enormous. Anxiety had to be remarketed and new
agents found to respond to it. And this is where depression started to
really take off as a diagnosis. First of all, however, it had to be
constructed as a discrete, well-defined clinical entity.
Why
couldn't the drugs companies have simply offered their products as
tonics or general mood enhancers? After the thalidomide scandal in the
early 60s, tough new standards were set in place and drugs had to
specify their active ingredients, the outcomes sought and the delivery
period for attaining them. This meant a new kind of surface precision.
Drugs would have to pass expensive trials proving they were more
effective than placebo and do better than other drugs used for this
same group of target patients. These new standards brought with them a
new technology to evaluate. Randomised controlled trials became the
norm, together with a silver bullet model of illness according to which
each specific disorder would have a specific cause and a specific
treatment.
These changes in the landscape of prescription
medicines framed the market for the antidepressants. Since the new
diagnosis needed to be publicised, drug companies paid for adverts in
medical journals, glossy pullout supplements, conferences and clinical
studies to show the prevalence of depression. When Frank Ayd wrote his
book Recognising the Depressed Patient, the pharmaceuticals giant Merck
bought 50,000 copies and distributed them to GPs. The book argued that
depression was going undetected and untreated in the community. This
dissemination of knowledge coincided nicely with their marketing of a
new treatment for depression in the form of amitriptyline.
The
later generation of SSRI drugs had an even more exponential success: by
the late 90s Prozac was a household word, with millions of
prescriptions and a whole cult of novels, films and memoirs based
around it. In 2005, traces of Prozac were even found to be present in
British tap water.
Only registered users can write comments. Please login or register. Powered by AkoComment 2.0! |
|
Last Updated ( Tuesday, 15 July 2008 )
|
Recent Posts
The Regina Streets Magazine [Regina Streets; 15-5-2008, 00:05:45]
Enterprise Saskatchewan [Malachi Constants; 13-3-2008, 03:03:32]
Enterprise Saskatchewan [Malachi Constants; 13-3-2008, 03:03:26]
Re:The Pirates of Penzance, SK [barrera; 6-12-2007, 16:12:06]
Re:The Pirates of Penzance, SK [John Hubris; 1-12-2007, 10:12:36]
Re:The Pirates of Penzance, SK [John Hubris; 1-12-2007, 10:12:32]
Re:The Pirates of Penzance, SK [pelliott; 1-12-2007, 07:12:57]
The Pirates of Penzance, SK [John Hubris; 26-11-2007, 23:11:34]
oops, please delete [John Hubris; 26-11-2007, 23:11:26]
Re:Leaders debate [wagmitfam; 31-10-2007, 14:10:29]
Show updated topics in last 4h - 24h
|
All logos and trademarks in this site are property of their respective owners. Opinions expressed in articles within this site are those of their owners and may not reflect the opinion of ActUpInSask.org, its staff, or its associates.
|
|
|